Insider Trading Signals — October 26, 2026 — Evening Update — Last 12 Hours (Pacific Time)

Executive Summary

Insider activity over the past 12 hours skewed heavily toward selling, with high-profile C-suite executives at Intuitive Surgical, Lam Research, United Therapeutics, and PACS Group collectively offloading tens of millions in shares. Notable exceptions include a coordinated cluster of buying at Stewart Information Services, a significant $24.2M institutional purchase in Group 1 Automotive, and Nippon Life's $8.66M stake increase in Corebridge Financial. The overall tone is cautiously bearish, though targeted cluster buying in select names warrants attention.

Activity Breakdown

Net Signal: 🟡 Mixed — Net buying of approximately +$2.3M, though this is heavily skewed by a few large institutional purchases. Excluding the Conifer/Group 1 and Nippon Life/Corebridge transactions, the underlying signal tilts bearish.

Top Notable Transactions

🔴 Intuitive Surgical (ISRG) — Strong Bearish Cluster

• Insider: Gary Guthart, Director (also CEO)
• Transaction: Sale of $9.08M (20,095 shares)
• Signal: Strong Bearish
• Context: The largest single transaction of the day, compounded by two additional ISRG insiders selling the same period — a notable cluster at one of the market's most richly valued medtech names.

🔴 Intuitive Surgical (ISRG) — Bearish Cluster

• Insider: Craig H. Barratt, Director
• Transaction: Sale of $510,370
• Signal: Moderate Bearish
• Context: Part of a three-insider selling cluster at ISRG, amplifying the bearish signal from Guthart's mega-sale.

🔴 Intuitive Surgical (ISRG) — Bearish Cluster

• Insider: Patricia L. Wadors, SVP & Chief Human Resources Officer
• Transaction: Sale of $478,416 (1,078 shares)
• Signal: Moderate Bearish
• Context: Third consecutive ISRG insider sale in the same window, making this the most significant cluster sell signal of the day.

🔴 Lam Research (LRCX) — Strong Bearish

• Insider: Timothy Archer, President & CEO
• Transaction: Sale of $7.1M (31,400 shares)
• Signal: Strong Bearish
• Context: A CEO selling $7M+ in a single transaction at a major semiconductor equipment company is a high-conviction signal worth monitoring closely.

🔴 Charles River Laboratories (CRL) — Strong Bearish

• Insider: James C. Foster, Director
• Transaction: Sale of $8.4M
• Signal: Strong Bearish
• Context: A substantial director-level sale at a key life sciences services company, adding to sector-wide selling pressure.

🔴 United Therapeutics (UTHR) — Bearish

• Insider: Martine A. Rothblatt, Chairperson & CEO
• Transaction: Sale of $5.5M (9,500 shares)
• Signal: Strong Bearish
• Context: CEO/Chair selling at this scale is among the most meaningful insider signals; Rothblatt's track record makes this transaction particularly notable.

🔴 PACS Group (PACS) — Bearish

• Insider: Jason Hulse Murray, Co-Founder, CEO & Chairman
• Transaction: Sale of $4.0M
• Signal: Strong Bearish
• Context: A founder-CEO liquidating $4M across multiple transactions signals reduced near-term conviction in the company's valuation.

🟢 Conifer Management / Group 1 Automotive (GPI) — Strong Bullish

• Insider: Conifer Management LLC, 10% Owner & Director
• Transaction: Purchase of $24.2M
• Signal: Strong Bullish
• Context: A 10% owner adding $24.2M in stock is one of the most bullish signals possible — insiders at this level buy for one reason.

🟢 Nippon Life / Corebridge Financial (CRBG) — Bullish

• Insider: Nippon Life Insurance Co., Director & 10% Owner
• Transaction: Purchase of $8.66M (246,440 shares)
• Signal: Strong Bullish
• Context: A major institutional insider adding nearly $9M reinforces strategic conviction in Corebridge's long-term trajectory.

🟢 Stewart Information Services (STC) — Bullish Cluster

• Insiders: Thomas G. Apel ($95,470), Bradley C. Allen Jr. ($94,600), Corey William S. Jr. ($93,640) — all Directors
• Transaction: Combined purchases of ~$283,710
• Signal: Moderate Bullish
• Context: Three directors buying simultaneously at the same company is a textbook cluster buy signal — coordinated conviction is hard to ignore.

🟢 Gentherm (THRM) — Bullish Cluster

• Insiders: Paul Mascarenas, Director ($532,600) + William T. Presley, President & CEO ($130,000)
• Transaction: Combined purchases of ~$662,600
• Signal: Strong Bullish
• Context: Both a director and the CEO buying in the same window at a beaten-down auto tech name is a meaningful double signal.

🔴 Globe Life (GL) — Bearish

• Insider: Michael Clay Majors, EVP & Chief Strategy Officer
• Transaction: Sale of $2.22M (14,377 shares)
• Signal: Moderate Bearish
• Context: A strategy-level executive liquidating $2.2M may reflect reduced confidence in the company's near-term outlook.

🔴 MSCI (MSCI) — Moderate Bearish

• Insider: Robert J. Gutowski, General Counsel
• Transaction: Sale of $1.48M (2,381 shares)
• Signal: Moderate Bearish
• Context: General counsel selling at a premium-valued financial data company adds to a broader pattern of insider distribution.

🔴 Heartflow (HTFL) — Moderate Bearish

• Insider: Campbell Rogers, Chief Medical Officer
• Transaction: Sale of $1.32M (23,933 shares)
• Signal: Moderate Bearish
• Context: A CMO selling over $1M at a medtech growth company warrants attention, particularly given the broader healthcare insider selling trend today.

🟢 Optimum Communications (OPTU) — Bullish

• Insider: Neil S. Subin, Director & 10% Owner
• Transaction: Purchase of ~$1.16M
• Signal: Strong Bullish
• Context: A 10% owner adding over $1M in a smaller-cap name is a high-conviction signal relative to company size.

🔴 Adaptive Biotechnologies (ADPT) — Bearish

• Insider: Julie Rubinstein, President & COO
• Transaction: Sale of ~$897K
• Signal: Moderate Bearish
• Context: A president and COO selling nearly $900K is a meaningful signal at a clinical-stage biotech where insider confidence matters most.

🟢 Korro Bio (KRRO) — Bullish

• Insider: Lynx1 Capital Management LP, 10% Owner & Director
• Transaction: Purchase of $884,751
• Signal: Moderate Bullish
• Context: A major shareholder adding nearly $900K in a small biotech signals continued conviction in the pipeline.

🔴 Dell Technologies (DELL) — Moderate Bearish

• Insider: Lynn Vojvodich Radakovich, Director
• Transaction: Sale of $930,120
• Signal: Moderate Bearish
• Context: Director-level selling at a large-cap tech name is worth noting, though single-director sales are less alarming than C-suite moves.

Pattern Analysis

🔴 Intuitive Surgical (ISRG) — Three-Insider Selling Cluster
Net Signal: Bearish | Companies: ISRG | Total Value: ~$10.07M
Three insiders — including the CEO/Director — sold shares in the same 12-hour window, making this the most concentrated cluster sell signal of the day. At ISRG's premium valuation, coordinated insider distribution is a meaningful caution flag.

🟢 Stewart Information Services (STC) — Three-Director Buying Cluster
Net Signal: Bullish | Companies: STC | Total Value: ~$283,710
Three separate directors independently purchased shares in the same window at nearly identical dollar amounts (~$93K–$95K each), suggesting coordinated conviction — a classic cluster buy pattern that historically carries outsized predictive value.

🟢 Gentherm (THRM) — CEO + Director Buying Cluster
Net Signal: Bullish | Companies: THRM | Total Value: ~$662,600
Both the CEO and a director purchased shares on the same day, with the director committing $532,600. When the person running the company and a board member both buy simultaneously, the signal is amplified.

🔴 Medtech/Biotech Insider Selling
Net Signal: Bearish | Companies: ISRG, CRL, HTFL, ADPT, UTHR | Total Value: ~$24.3M
Five companies across the healthcare/medtech/biotech space saw significant insider selling in a single 12-hour window, suggesting sector-wide caution among those with the most visibility into business conditions.

🔴 Large-Cap C-Suite Liquidation
Net Signal: Bearish | Companies: LRCX, UTHR, PACS, GL | Total Value: ~$18.8M
CEOs and senior executives at four prominent companies collectively sold nearly $19M in shares, pointing to a broader pattern of executive-level distribution at elevated valuations.

🟢 Institutional 10% Owner Accumulation
Net Signal: Bullish | Companies: GPI, CRBG, OPTU, KRRO | Total Value: ~$35.0M
Four 10%-or-greater owners added to positions in the same window, with Conifer Management's $24.2M GPI purchase leading the charge. This category of insider — large strategic holders — tends to have the longest time horizon and deepest conviction.

Sector Breakdown

Financial Services / Banking (🟢 Mildly Bullish)

• Net Signal: +~$700K net buying
• Notable: CCBG, PEBK, BY, SMBK, AUB, FIBK, BBT
• Context: Community and regional bank insiders showed mixed activity, with small-scale purchases at multiple names partially offset by EVP-level sales at Atlantic Union and First Interstate.

Insurance / Diversified Financials (🟢 Bullish)

• Net Signal: +~$8.66M net buying
• Notable: CRBG, GL, GS
• Context: Nippon Life's large Corebridge purchase dominates this sector positively, though Globe Life's EVP sale and Goldman's CAO sale temper the overall signal.

Healthcare / Medtech / Biotech (🔴 Bearish)

• Net Signal: -~$24M net selling
• Notable: ISRG, CRL, UTHR, HTFL, ADPT, GRCE, KRRO
• Context: Heavy insider selling across the healthcare complex is the dominant sector story today, with only small biotech purchases (GRCE, KRRO) providing any counterbalance.

Semiconductors / Technology (🔴 Bearish)

• Net Signal: -~$8.5M net selling
• Notable: LRCX, DELL, MSCI, PATH, AVPT, PENG
• Context: Tech insiders were consistent sellers, led by Lam Research's CEO offloading $7.1M — a meaningful signal in a sector trading at elevated multiples.

Automotive / Industrial (🟢 Bullish)

• Net Signal: +~$24.9M net buying
• Notable: GPI, THRM
• Context: The standout bullish sector of the day, driven by Conifer Management's $24.2M Group 1 Automotive purchase and coordinated CEO/director buying at Gentherm.

Real Estate / Title Insurance (🟢 Bullish)

• Net Signal: +~$283K net buying
• Notable: STC
• Context: The three-director cluster buy at Stewart Information Services is the cleanest bullish signal in this sector.

Communications / Telecom (🟢 Bullish)

• Net Signal: +~$1.16M net buying
• Notable: OPTU
• Context: A 10% owner adding over $1M at Optimum Communications stands out as a high-conviction small-cap buy.

Market Implications

The dominant theme from today's insider activity is a tale of two markets: institutional and strategic insiders (10%+ owners) are buying aggressively in select names, while C-suite executives at large-cap growth companies are quietly distributing. The $24.2M Group 1 Automotive purchase and Nippon Life's $8.66M Corebridge accumulation suggest that patient, long-horizon capital sees value in certain cyclical and financial names — even as equity markets remain elevated.

The healthcare and technology sectors are flashing the clearest caution signals. Five healthcare companies saw meaningful insider selling totaling over $24M, and the three-insider cluster at Intuitive Surgical is particularly notable given the stock's premium valuation. When a CEO, a director, and a senior HR executive all sell in the same window, it's rarely coincidental. Similarly, Lam Research's CEO selling $7.1M in semiconductor equipment stock deserves attention heading into what could be a pivotal period for the chip cycle.

On the bullish side, cluster buying remains the highest-quality signal in insider analysis — and today delivered two clean examples: Stewart Information Services (three directors, ~$283K combined) and Gentherm (CEO + director, ~$663K combined). These are smaller in dollar terms than the mega-sales, but historically, coordinated insider buying at the same company in the same window has been one of the more reliable forward-looking signals available to retail investors.

Key Takeaways

• 🔴 Intuitive Surgical (ISRG) — Three insiders including the CEO sold a combined ~$10M; the most significant cluster sell signal of the day.
• 🔴 Lam Research (LRCX) — CEO Timothy Archer sold $7.1M; C-suite liquidation at a major semis name warrants close monitoring.
• 🔴 Charles River Laboratories (CRL) — Director James Foster sold $8.4M; one of the largest single transactions of the session.
• 🔴 United Therapeutics (UTHR) — CEO/Chair Martine Rothblatt sold $5.5M; founder-level selling is among the most meaningful bearish signals.
• 🔴 PACS Group (PACS) — Founder-CEO sold $4M; insider distribution at the top of the org chart is a red flag.
• 🟢 Group 1 Automotive (GPI) — Conifer Management (10% owner) bought $24.2M; the single largest bullish transaction of the day by a wide margin.
• 🟢 Corebridge Financial (CRBG) — Nippon Life (10% owner) added $8.66M; strategic institutional accumulation signals long-term conviction.
• 🟢 Stewart Information Services (STC) — Three directors bought ~$283K combined in the same window; textbook cluster buy signal.
• 🟢 Gentherm (THRM) — CEO + director bought ~$663K combined; dual insider buying at an auto tech name suggests the selloff may be overdone.
• 🔴 Healthcare sector broadly — Five companies (ISRG, CRL, UTHR, HTFL, ADPT) saw combined insider selling of ~$24M; sector-wide caution from those with the most visibility.
• 🟢 Optimum Communications (OPTU) — 10% owner Neil Subin bought ~$1.16M; high-conviction signal in a smaller-cap name.
• 🟢 Korro Bio (KRRO) — 10% owner Lynx1 Capital added ~$885K; continued insider accumulation in a small biotech.
• 🔴 Globe Life (GL) — EVP/Chief Strategy Officer sold $2.22M; strategy-level selling may reflect internal visibility into near-term headwinds.
• 🟡 Overall ratio — 22 buys vs. 23 sells with near-parity in dollar volume (~$38.5M vs. ~$36.2M); the mixed signal masks a bifurcated market between strategic accumulators and executive distributors.
• 🟢 Cluster buying is the signal — Both confirmed cluster buys today (STC, THRM) involve multiple insiders acting independently in the same direction — historically the most reliable insider signal type.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/